Clinical Trials
11 trialsNCT05195970 2026-04-17
Walnuts and Colon Health
UConn Health
Phase NA Completed
NCT04038619 2026-03-20
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT03819296 2026-03-11
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT04305145 2026-01-29
Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis
Massachusetts General Hospital
Phase 2 Active not recruiting
NCT04407247 2025-12-23
Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma
M.D. Anderson Cancer Center
Phase 1/2 Active not recruiting
NCT06206707 2025-11-17
Immunobiome
University of Aarhus
Phase NA Recruiting
NCT02814864 2021-08-03
PRISME
Assistance Publique - Hôpitaux de Paris
Phase 2 Unknown
NCT03601611 2020-04-21
COLAR
Herlev Hospital
Phase NA Completed
NCT03548948 2019-09-27
Obesity, Iron Regulation and Colorectal Cancer Risk
University of Illinois at Chicago
Phase NA Completed
NCT00533078 2015-07-23
LUNCH1
Insel Gruppe AG, University Hospital Bern
Phase 2 Completed
NCT00237276 2007-09-24
Experience and Enhancement: Improving Colonoscopic Polyp Detection
London North West Healthcare NHS Trust
Phase NA Unknown